UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

Gut, 2005-01, Vol.54 (1), p.91-96

2005

Volltextzugriff (PDF)

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004

Gut, 2006-09, Vol.55 (9), p.1248-1254

2006

Volltextzugriff (PDF)

Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival

Gut, 2000-03, Vol.46 (3), p.336-343

2000

Volltextzugriff (PDF)

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

Gut, 2001-11, Vol.49 (5), p.656-664

2001

Volltextzugriff (PDF)

Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival

Gastroenterology (New York, N.Y. 1943), 1998-06, Vol.114 (6), p.1161-1168

1998

Volltextzugriff (PDF)

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

Gut, 2001-11, Vol.49 (5), p.665-670

2001

Volltextzugriff (PDF)

Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort

Gastroenterology (New York, N.Y. 1943), 1999-07, Vol.117 (1), p.49-57

1999

Volltextzugriff (PDF)

Clinical Outcome Following Treatment of Refractory Inflammatory and Fistulizing Crohn's Disease With Intravenous Cyclosporine

The American journal of gastroenterology, 1998-03, Vol.93 (3), p.442-448

1998

Volltextzugriff (PDF)

Immune modulator therapy for microscopic colitis in a case series of 73 patients

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.169-174

2017

Volltextzugriff (PDF)

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota

Gut, 2007-04, Vol.56 (4), p.504-508

2007

Volltextzugriff (PDF)

Age at onset of inflammatory bowel disease and the risk of surgery for non‐neoplastic bowel disease

Alimentary pharmacology & therapeutics, 2007-06, Vol.25 (12), p.1435-1441

2007

Volltextzugriff (PDF)

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study

Alimentary pharmacology & therapeutics, 2002-03, Vol.16 (3), p.407-413

2002

Volltextzugriff (PDF)

Successful management of Crohn's disease of the ileoanal pouch with infliximab

Gastroenterology (New York, N.Y. 1943), 1999-08, Vol.117 (2), p.429-432

1999

Volltextzugriff (PDF)

Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index

Mayo Clinic proceedings, 1994-05, Vol.69 (5), p.409-415

1994

Volltextzugriff (PDF)

Acute major gastrointestinal hemorrhage in inflammatory bowel disease

Gastrointestinal endoscopy, 1999-02, Vol.49 (2), p.153-157

1999

Volltextzugriff (PDF)

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial

Gastroenterology (New York, N.Y. 1943), 2001-11, Vol.121 (5), p.1088-1094

2001

Volltextzugriff (PDF)

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1995-12, Vol.109 (6), p.1808-1817

1995

Volltextzugriff (PDF)

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.19-31

2004

Volltextzugriff (PDF)

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1997-03, Vol.126 (5), p.364

1997

Volltextzugriff (PDF)

Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2203-2208

2012

Volltextzugriff (PDF)

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients

Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (1), p.99-107

2015

Volltextzugriff (PDF)

Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (4), p.428-440

2015

Volltextzugriff (PDF)

Correlation of C‐reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

Inflammatory bowel diseases, 2005-08, Vol.11 (8), p.707-712

2005

Volltextzugriff (PDF)

Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double‐blind, placebo‐controlled trial

Alimentary pharmacology & therapeutics, 1997-12, Vol.11 (6), p.1041-1046

1997

Volltextzugriff (PDF)

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

Gastroenterology (New York, N.Y. 1943), 1996-02, Vol.110 (2), p.432-440

1996

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(119)

Sprache

Englisch
(119)

Erscheinungsjahr

n.n

Thema

Humans
(119)
Female
(111)
Life Sciences & Biomedicine
(111)
Science & Technology
(111)
Male
(109)
Middle Aged
(101)
Gastroenterology & Hepatology
(91)
Aged
(70)
Biological And Medical Sciences
(69)
Medical Sciences
(69)
Adolescent
(57)
Gastroenterology. Liver. Pancreas. Abdomen
(39)
Other Diseases. Semiology
(36)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(36)
Aged, 80 And Over
(33)
Retrospective Studies
(26)
Pharmacology. Drug Treatments
(25)
Child
(24)
Crohn Disease - Drug Therapy
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004

Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort

Clinical Outcome Following Treatment of Refractory Inflammatory and Fistulizing Crohn's Disease With Intravenous Cyclosporine

Immune modulator therapy for microscopic colitis in a case series of 73 patients

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota

Age at onset of inflammatory bowel disease and the risk of surgery for non‐neoplastic bowel disease

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open‐label pilot study

Successful management of Crohn's disease of the ileoanal pouch with infliximab

Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index

Acute major gastrointestinal hemorrhage in inflammatory bowel disease

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients

Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice

Correlation of C‐reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double‐blind, placebo‐controlled trial

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

Aktive Filter

Suchergebnisse filtern